Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 913-660-8 | CAS number: -
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Toxicity to reproduction
Administrative data
- Endpoint:
- screening for reproductive / developmental toxicity
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- 2012
- Reliability:
- 2 (reliable with restrictions)
Data source
Reference
- Reference Type:
- study report
- Title:
- Unnamed
- Year:
- 2 012
Materials and methods
Test guideline
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 421 (Reproduction / Developmental Toxicity Screening Test)
- Deviations:
- no
- GLP compliance:
- yes
Test material
- Reference substance name:
- N-[3-(dimethylamino)propyl]stearamide
- EC Number:
- 231-609-1
- EC Name:
- N-[3-(dimethylamino)propyl]stearamide
- Cas Number:
- 7651-02-7
- Molecular formula:
- C23H48N2O
- IUPAC Name:
- N-[3-(dimethylamino)propyl]octadecanamide
- Test material form:
- other: white pellets
Constituent 1
Test animals
- Species:
- rat
- Strain:
- Wistar
- Sex:
- male/female
- Details on test animals or test system and environmental conditions:
- Rat: Crl:WI(Han) (outbred, SPF-Quality). Nulliparous and non-pregnant
females and untreated animals were used at initiation of the study.
Rationale This species and strain of rat has been recognized as appropriate for
general and reproduction toxicity studies. WIL Research Europe B.V. has
general and reproduction/developmental historical data in this species
from the same strain and source. This animal model has been proven to
be susceptible to the effects of reproductive toxicants.
Source F0 Charles River Deutschland, Sulzfeld, Germany.
Age at start F0-treatment Approximately 11 weeks.
Number of F0-animals 40 females and 40 males.
Acclimatization F0 At least 5 days prior to start of treatment.
Health inspection F0 Upon receipt of the animals.
Randomization F0 Prior to commencement of treatment, by computer-generated random
algorithm according to body weight, with all animals within ± 20% of the
sex mean.
Identification F0 Earmark and tattoo.
Mating procedures Following a minimum of 14 days of exposure for the males and females,
one female was cohabitated with one male of the same treatment group,
avoiding sibling mating. Detection of mating was confirmed by evidence
of sperm in the vaginal lavage or by the appearance of an intravaginal
copulatory plug. This day was designated Day 0 post-coitum. Once
mating occurred, the males and females were separated. Female no. 77
was mated with a proven male of the same dose group since the male
that she was intended to be mated with was sacrificed before mating.
A maximum of 14 days was allowed for mating, after which females who
had not shown evidence of mating were separated from their males.
Parturition The females were allowed to litter normally. Day 1 of lactation was
defined as the day when a litter was found completed (i.e. membranes
and placentas cleaned up, nest build up and/or feeding of pups started).
Females that were littering were left undisturbed.
Number of pups 423 pups.
Identification of pups On Day 1 of lactation, all pups were individually identified by means of
subcutaneous injection of Indian ink.
Administration / exposure
- Route of administration:
- oral: gavage
- Vehicle:
- propylene glycol
- Details on exposure:
- Parental animals
Method Oral gavage, using a plastic feeding tube. Formulations were placed on a
magnetic stirrer during dosing.
Dose volume 5 mL/kg body weight. Actual dose volumes were calculated according to
the latest body weight.
Frequency Once daily for 7 days per week, approximately the same time each day
with a maximum of 6 hours difference between the earliest and latest
dose. Animals were dosed up to the day prior to scheduled necropsy.
Exposure period Males were exposed for 28 days, i.e. 2 weeks prior to mating, during
mating, and up to the day prior to scheduled necropsy. Females were
exposed for 41 - 54 days, i.e. during 2 weeks prior to mating, during
mating, during post-coitum, and during at least 4 days of lactation (up to
the day prior to scheduled necropsy). Female no. 47 (Group 1) was not
dosed during littering. - Details on mating procedure:
- Accommodation
Pre-mating Animals were housed in groups of 5 animals/sex/cage in Macrolon plastic
cages (MIV type, height 18 cm).
Mating Females were caged together with males on a one-to-one-basis in
Macrolon plastic cages (MIII type, height 18 cm).
Post-mating Males were housed in their home cage (Macrolon plastic cages, MIV type,
height 18 cm) with a maximum of 5 animals/cage. Females were
individually housed in Macrolon plastic cages (MIII type, height 18 cm).
Lactation Pups were kept with the dam until termination in Macrolon plastic cages
(MIII type, height 18 cm). - Duration of treatment / exposure:
- Males were exposed for 28 days, i.e. 2 weeks prior to mating, during
mating, and up to the day prior to scheduled necropsy. Females were
exposed for 41 - 54 days, i.e. during 2 weeks prior to mating, during
mating, during post-coitum, and during at least 4 days of lactation (up to
the day prior to scheduled necropsy). Female no. 47 (Group 1) was not
dosed during littering - Frequency of treatment:
- Once daily for 7 days per week, approximately the same time each day
with a maximum of 6 hours difference between the earliest and latest
dose. Animals were dosed up to the day prior to scheduled necropsy.
Doses / concentrations
- Dose / conc.:
- 5 mg/kg bw/day
- No. of animals per sex per dose:
- 10 female 10 male
Examinations
- Parental animals: Observations and examinations:
- Mortality / Viability At least twice daily. Animals showing pain, distress or discomfort, which
was considered not transient in nature or was likely to become more
severe, were sacrificed for humane reasons based on OECD guidance
document on humane endpoints (ENV/JM/MONO/ 2000/7). The
circumstance of any death was recorded in detail.
Clinical signs At least once daily from start of treatment onwards, detailed clinical
observations were made in all animals.
The time of onset, grade and duration of any observed sign was
recorded. Signs were graded for severity and the maximum grade was
predefined at 3 or 4. Grades were coded as slight (grade 1), moderate
(grade 2), severe (grade 3) and very severe (grade 4). For certain signs,
only its presence (grade 1) or absence (grade 0) was scored. In the data
tables, the scored grades were reported, as well as the percentage of
animals affected in summary tables.
Body weights Males and females were weighed on the first day of exposure and weekly
thereafter. Mated females were weighed on Days 0, 4, 7, 11, 14, 17 and
20 post-coitum and during lactation on Days 1 and 4. On Day 11 of the
premating period, Group 4 animals were additionally weighed to monitor
their health status (results are retained in the raw data but have not been
reported). Group 4 males were weighed daily from Days 12-14 of the
premating period in order to correct the actual dose volume for lower
body weights recorded for these animals on a daily basis. Body weights
determined daily between the regular body weight determinations (i.e. on
Days 1, 8, 15, 22 and 28) are not reported since these were intended for
calculation of the actual dose volumes only.
Food consumption Weekly, except for males and females which were housed together for
mating and for females without evidence of mating. Food consumption of
mated females was measured on Days 0, 4, 7, 11, 14, 17 and 20 postcoitum
and on Days 1 and 4 of lactation.
Water consumption Subjective appraisal was maintained during the study, but no quantitative
investigation was introduced as no treatment related effect was
suspected.
General reproduction data Male number paired with, mating date, confirmation of pregnancy, and
delivery day were recorded. Pregnant females were examined to detect
signs of difficult or prolonged parturition, and cage debris of pregnant
females was examined to detect signs of abortion or premature birth. Any
deficiencies in maternal care (such as inadequate construction or
cleaning of the nest, pups left scattered and cold, physical abuse of pups
or apparently inadequate lactation or feeding) were examined
Results and discussion
Results: P0 (first parental generation)
General toxicity (P0)
- Clinical signs:
- no effects observed
- Description (incidence and severity):
- Clinical signs at 200 mg/kg (including hunched posture, rales,
piloerection and lean appearance) were essentially reversible - Mortality:
- no mortality observed
- Body weight and weight changes:
- effects observed, non-treatment-related
- Description (incidence and severity):
- Reversible changes in body weight and food intake for males at 200 mg/kg were considered not
adverse in nature - Food consumption and compound intake (if feeding study):
- effects observed, non-treatment-related
- Description (incidence and severity):
- slightly lower lower food intake and body weight in females at this dose
during post-coitum/lactation. - Clinical biochemistry findings:
- no effects observed
- Organ weight findings including organ / body weight ratios:
- no effects observed
Reproductive function / performance (P0)
- Reproductive function: oestrous cycle:
- no effects observed
- Reproductive function: sperm measures:
- no effects observed
- Reproductive performance:
- no effects observed
Effect levels (P0)
open allclose all
- Key result
- Dose descriptor:
- NOAEL
- Effect level:
- > 200 mg/kg bw/day (nominal)
- Based on:
- test mat.
- Sex:
- male/female
- Basis for effect level:
- reproductive function (oestrous cycle)
- reproductive function (sperm measures)
- reproductive performance
- Key result
- Dose descriptor:
- NOAEL
- Effect level:
- > 200 mg/kg bw/day (nominal)
- Based on:
- test mat.
- Sex:
- male/female
- Basis for effect level:
- clinical signs
Results: F1 generation
General toxicity (F1)
- Clinical signs:
- no effects observed
- Mortality / viability:
- no mortality observed
- Body weight and weight changes:
- no effects observed
- Food consumption and compound intake (if feeding study):
- no effects observed
- Ophthalmological findings:
- no effects observed
- Haematological findings:
- no effects observed
- Clinical biochemistry findings:
- no effects observed
- Organ weight findings including organ / body weight ratios:
- no effects observed
- Gross pathological findings:
- no effects observed
- Histopathological findings:
- no effects observed
Developmental neurotoxicity (F1)
- Behaviour (functional findings):
- no effects observed
Effect levels (F1)
- Key result
- Dose descriptor:
- NOAEL
- Generation:
- F1
- Effect level:
- > 200 mg/kg bw/day (nominal)
- Based on:
- test mat.
- Sex:
- male/female
- Basis for effect level:
- sexual maturation
- clinical signs
- mortality
- ophthalmological examination
Overall reproductive toxicity
- Key result
- Reproductive effects observed:
- no
Applicant's summary and conclusion
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.